Li Yang, Sun Mingwei, Hu Yechen, Shan Yichu, Liang Zhen, Zhang Lihua, Zhang Yukui
CAS Key Laboratory of Separation Science for Analytical Chemistry, National Chromatographic R. & A. Center, Dalian Institute of Chemical Physics, Chinese Academy of Science, Dalian, 116023, China; University of Chinese Academy of Sciences, Beijing, 100039, China.
CAS Key Laboratory of Separation Science for Analytical Chemistry, National Chromatographic R. & A. Center, Dalian Institute of Chemical Physics, Chinese Academy of Science, Dalian, 116023, China; Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Guangzhou, 510005, China.
Anal Chim Acta. 2021 Apr 15;1154:338324. doi: 10.1016/j.aca.2021.338324. Epub 2021 Feb 16.
SUMOylation is a reversible post-translational modification that plays crucial roles in numerous cellular processes. Although anti-SUMO antibodies have been applied to analyze exogenous and endogenous SUMOylation, such immunoprecipitation enrichment strategy is applicable only for the enrichment of one specific SUMO type in mammalian cells, unable to map the global landscape of all endogenous SUMOylation simultaneously. To address this issue, we proposed an antibody-free strategy to enrich and profile endogenous SUMO1/2/3-modified peptides simultaneously. Upon trypsin digestion, the SUMO1- and SUMO2/3-modified peptides contained SUMO remnants with 7 and 9 acidic amino acids respectively, which carried more negative charges at high pH and could interact with strong anion exchange (SAX) materials more strongly than non-SUMOylated peptides, thus enabling the specific enrichment of endogenous SUMOylated peptides. Followed by the secondary digestion with Asp-N/Glu-C to generate smaller SUMOylated peptides with proper length for MS identification, off-line high-pH C18 pre-fractionation and low pH nanoRPLC-ESI-MS/MS analysis, 177 SUMO1-modified sites and 74 SUMO2/3-modified sites were unbiasedly identified in HeLa cell lysate. To the best of our knowledge, this was the first antibody-free strategy to comprehensively profile various endogenous SUMOylation sites, demonstrating the great potential in the comprehensive analysis of endogenous SUMOylation across various species and organs, which might further facilitate the understanding of SUMO's function in physiology and pathology.
SUMO化是一种可逆的翻译后修饰,在众多细胞过程中发挥着关键作用。尽管抗SUMO抗体已被用于分析外源性和内源性SUMO化,但这种免疫沉淀富集策略仅适用于富集哺乳动物细胞中一种特定的SUMO类型,无法同时绘制所有内源性SUMO化的全局图谱。为了解决这个问题,我们提出了一种无抗体策略,用于同时富集和分析内源性SUMO1/2/3修饰的肽段。胰蛋白酶消化后,SUMO1和SUMO2/3修饰的肽段分别含有带有7个和9个酸性氨基酸的SUMO残余物,这些残余物在高pH值下带有更多负电荷,并且比未SUMO化的肽段与强阴离子交换(SAX)材料的相互作用更强,从而能够特异性富集内源性SUMO化的肽段。接着用天冬氨酸-N/谷氨酸-C进行二次消化,以生成长度合适的较小SUMO化肽段用于质谱鉴定,离线高pH值C18预分级分离和低pH值纳升反相液相色谱-电喷雾串联质谱分析,在HeLa细胞裂解物中无偏倚地鉴定出了177个SUMO1修饰位点和74个SUMO2/3修饰位点。据我们所知,这是第一种全面分析各种内源性SUMO化位点的无抗体策略,显示出在跨物种和器官全面分析内源性SUMO化方面的巨大潜力,这可能进一步有助于理解SUMO在生理和病理中的功能。